Roche Reveals Impact Of Multisource Biosimilar Competition

Avastin, Rituxan and Herceptin All Face Challengers

 
• By Dean Rudge
  
Roche
Roche acknowledges competition this year will be significant • Source: Shutterstock

More from Biosimilars

More from Products